SLAMF8 and melanoma: The expression of SLAMF8 (Zhang et al., 2021b) and PSMB8 (Kalaora et al., 2020) could predict the efficacy of immune checkpoint inhibitor immunotherapy in gastrointestinal cancer and melanoma.